Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    P1.11 - Poster Session 1 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 45
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.11-012 - Clinical observation from the treatment of icotinib for 196 cases with advanced non-small cell lung cancer

      09:30 - 09:30  |  Author(s): Q.A. Gu

      • Abstract

      Loading...

    • +

      P1.11-036 - The efficacy and safety of sunitinib in EGFR-TKI pretreated advanced non-small cell lung cancer: a retrospective review from Chinese patients at a single institution

      09:30 - 09:30  |  Author(s): L. Jiang

      • Abstract

      Loading...

    • +

      P1.11-039 - A randomized phase II trial of celecoxib combined with platinum-based chemotherapy as first-line and with icotinib as second-line treatment for advanced non-small cell lung cancer

      09:30 - 09:30  |  Author(s): T. Chu

      • Abstract

      Loading...

  • +

    P2.06 - Poster Session 2 - Prognostic and Predictive Biomarkers

    • Type: Poster Session
    • Track: Biology
    • Presentations: 50
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.06-027 - Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients

      09:30 - 09:30  |  Author(s): L. Jiang

      • Abstract

      Loading...

  • +

    P2.12 - Poster Session 2 - NSCLC Early Stage

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 23
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.12-001 - Erlotinib as neoadjuvant treatment in patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) with activating Epidermal Growth Factor Receptor (EGFR) mutation (NCT01217619, EASTERN): study update

      09:30 - 09:30  |  Author(s): B. Han

      • Abstract

      Loading...